Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients

OBJECTIVE: In an effort to account for deficiencies in axonal transport that limit the effectiveness of neurotrophic factors, this study tested the safety and feasibility, in moderately advanced Parkinson disease (PD), of bilaterally administering the gene therapy vector AAV2-neurturin (CERE-120) to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bartus, Raymond T., Baumann, Tiffany L., Siffert, Joao, Herzog, Christopher D., Alterman, Ron, Boulis, Nicholas, Turner, Dennis A., Stacy, Mark, Lang, Anthony E., Lozano, Andres M., Olanow, C. Warren
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3716474/
https://ncbi.nlm.nih.gov/pubmed/23576625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182904faa
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars